1. Background {#sec131831}
=============

Palpitation, defined as an unpleasant awareness of the beating of the heart, is one of the most common complaints in patients referring to cardiac clinics (11% - 40%) ([@A22615R1]-[@A22615R4]). The etiology of palpitation determined by a study was cardiac in 43%, psychiatric in 31%, miscellaneous in 10%, and unknown in 16% of cases ([@A22615R4]). Although some palpitations may be an indication of life-threatening cardiac arrhythmias, most of them are benign without any serious underlying heart disease ([@A22615R5]). Benign palpitations, which are generally considered as palpitations without any more serious underlying heart disease, despite its good prognosis, causes considerable distress and disability among affected patients ([@A22615R6]).

Despite its high prevalence, in many cases, the diagnostic and therapeutic management of this symptom proved to be poorly efficacious and lead to permanent distress and disability in patients and continual recourse to healthcare facilities ([@A22615R7]). One study has shown that 84% of patients still reported palpitations after 6-month follow-up consultation ([@A22615R8]). Today, most research has focused on other cardiovascular patients, whereas less attention has been given to those with palpitation ([@A22615R1]). There is some evidence of an association between psychiatric disorders and a subsequent poor outcome in patients suffering from palpitation ([@A22615R1]). Palpitations are one of the DSM-III-R diagnostic criteria for panic attack, somatization disorder, and generalized anxiety disorder ([@A22615R4]). Although some studies indicated the strong correlation of cardiovascular symptoms to emotional distress ([@A22615R9]), to the best of our knowledge, no screening of Iranian patients with benign palpitations for psychiatric disorders has been performed so far. Thus, there is a need for an evaluation of the mental health of these patients, and this study aimed to evaluate the mental health condition in these patients in order to compare it with their matched healthy persons.

2. Objectives {#sec131832}
=============

This study was done to evaluate the relationship between palpitation symptom and mental health by comparing the mental health status of patients suffering from benign palpitations to their matched healthy persons. Thus, after separating patients suffering from benign palpitations from those with dangerous ones, using current diagnostic strategies ([@A22615R2], [@A22615R10], [@A22615R11]), the comparison of the mental health condition between groups was done.

3. Patients and Methods {#sec131833}
=======================

This study used accidental sampling method. Eligible participants were volunteers who were adult outpatients with palpitation (an unpleasant sensation in the heart or awareness of heartbeat) as their main complaint, as well as the matched group of healthy volunteers. Volunteers were called through advertisement. Patients were initially screened by a short interview on the phone to determine palpitation characteristics in order to take a brief record of each patient's medical history, including their health problems and medications to check the inclusion criteria.

Inclusion criteria were as follows: having palpitations (abnormal awareness of heartbeat) as the main complaint for at least three months; aged between 18 and 60 years; and giving their informed consent. Volunteers who met at least one exclusion criterion were not included in the trial. Exclusion criteria were as follows: having mental retardation, psychosis, or other serious psychiatric disorders confirmed by a psychiatrist; having organic heart diseases confirmed by a cardiologist; and suffering from serious chronic diseases. After primary selection of the eligible patients, they were invited to the outpatient cardiac clinic of Mostafa Khomeini hospital. It is a general hospital with 280 beds and 9 hospital sections, which is a semi-governmental hospital affiliated to Shahed university. Each patient's medical history was checked by a cardiologist, and each had a physical examination, an electrocardiography test, and biochemical laboratory tests to identify those patients suffering from serious problems considered under the exclusion criteria.

Patients' mental health was evaluated and they were screened for probable disorders by means of GHQ-28. Furthermore, healthy participants selected from accessible volunteers working in telecommunication office, non-governmental companies or were housekeepers, of similar age, gender, and educational degree, were included in the study. They were also evaluated for mental health and screened for probable disorders by means of GHQ-28.

An Iranian version of the 28-item general health questionnaire (GHQ-28) was used as the measuring tool. It is a brief, simple, consistent and reliable instrument, and one of the most well-known questionnaires for the detection of mental disorders. This questionnaire was developed by Goldberg and Hillier (1979) for screening somatic symptoms, anxiety, insomnia, social dysfunction, and severe depression ([@A22615R12]). It has been translated into 38 different languages ([@A22615R13]) as well as the official language of Iran (Persian) and its validity and reliability were approved in an independent study ([@A22615R14]). Also, other studies on the validation of the GHQ-28 in different countries demonstrate its high validity and reliability as a screening tool of mental disorders in the community ([@A22615R15], [@A22615R16]).

The study used the Likert scoring method, in which the maximum score was 84. The cut-off point was 23 out of the total score and 6 in every subscale; thus, patients with the equal or higher than cut-off point scores were deemed as having a psychological disorder. Sensitivity, specificity, and overall misclassification rate for a GHQ-28 cut-off score of 6 were 84.7, 93.8, and 8.2%, respectively. The reliability of the GHQ-28 was assessed in a sample of 90 participants retested 1 week after the initial referral. The estimated intraclass correlation between the test-retest scores was 0.85 ([@A22615R17]).

Each item is accompanied by four possible responses of typically 'not at all,' 'no more than usual,' 'rather more than usual,' and 'much more than usual,' scoring from 0 to 3, respectively.

The total possible score on the GHQ-28 ranges from 0 to 84 and allows for means and distributions to be calculated, both for the global total, as well as for the 4 sub-scales ([@A22615R18]).

This study was performed alongside with a clinical trial, which was approved by Medical Ethics Committee of Shahid Beheshti University of Medical Sciences (accession No. 111, 2012 - 1 - 7). Regarding the ethical consideration, all participants provided written informed consent; they could ask any question and leave the study whenever they wish, also data privacy was considered. According to previous data from pilot and other studies and considering: α = 0.05, β = 0.20, σ = 12, and Δ = 7, the sample size was calculated by the following formula as at least 46 in every group ([Equation 1](#EQ4199){ref-type="disp-formula"}). So total sample size of 110, was considered suitable for compensating the probable exclusion of some participants.
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Using SPSS software (version 20), normal distribution was checked by Kolmogorov-Smirnov test. Independent samples t test was performed for scores of questionnaire due to normal distribution. The Chi-square test was applied to compare demographic data. It also used for comparing the number of patients with scores more than the cut-off point between the groups due to lack of normal distribution. Data are presented as means ± standard deviations (SD) and proportions (%). Differences were considered significant with P \< 0.05.

4. Results {#sec131834}
==========

Out of 109 primary volunteer patients, 55 were included in this study. Thirty-eight patients excluded because of refusing to participate or not meeting inclusion criteria and 16 patients excluded because of their incomplete questionnaires. In addition, 55 healthy volunteers who were matched to patients group considering their age, sex, and degree of education, were included. The mean age of participants was 40.1 ± 11.3 y; and 63.6% of them were female ([Table 1](#tbl34044){ref-type="table"}). Their age ranged from 18 to 60 y. The most common educational degree was diploma (39.1%).

###### Comparison Between Two Groups; Patients With Heart Palpitation and Healthy Persons^[a](#fn36040){ref-type="table-fn"},[b](#fn36041){ref-type="table-fn"}^

  Demographic Data           Healthy Persons   Patients With Palpitation   P Value
  -------------------------- ----------------- --------------------------- ---------
  **Age, y**                 38.4 ± 11.3       41.8 ± 11.4                 .116
  **Gender**                 35 (63.6)         35 (63.6)                   ˃.999
  **Educational level, y**   13.7 ± 3.6        13.2 ± 2.8                  .195

^a^N = 55.

^b^Data are presented as mean ± SD or No. (%) (for females).

There was no significant difference with respect to age, gender, and degree of education between the two groups (patients and healthy volunteers) ([Table 1](#tbl34044){ref-type="table"}).

Results showed that, 24 out of 55 participants (43.6%) in the healthy persons group and 47 out of 55 participants (85.4%) in the patients group did not have a proper state of mental health (according to the scores that were above the cut-off point). There is a significant difference between the groups (P \< 0.001).

According to the four subscales of mental health, as shown in [Table 2](#tbl34045){ref-type="table"}, the most prevalent disorder was social dysfunction and the least prevalent one was depression. The rate of disorder with respect to somatization and anxiety in patients with palpitation was significantly more than healthy participants.

###### Frequency of Participants With Disorder of Mental Health According to Subscales of GHQ-28^[a](#fn36042){ref-type="table-fn"}^

  Aspect of Mental Health     Number of Patients With Disorder   Percentage of Participants With Disorder   P Value
  --------------------------- ---------------------------------- ------------------------------------------ ---------
  **Total score**                                                                                           \< .001
  Patients with palpitation   47                                 85.4                                       
  Healthy persons             24                                 43.6                                       
  **Somatization**                                                                                          \< .001
  Patients with palpitation   45                                 81.8                                       
  Healthy persons             23                                 41.8                                       
  **Anxiety**                                                                                               \< .004
  Patients with palpitation   44                                 80                                         
  Healthy persons             30                                 54.6                                       
  **Social dysfunction**                                                                                    \< .081
  Patients with palpitation   53                                 96.4                                       
  Healthy persons             48                                 87.2                                       
  **Depression**                                                                                            \< .238
  Patients with palpitation   13                                 23.6                                       
  Healthy persons             9                                  16.4                                       

^a^Data are presented for a study group of n = 55.

As shown in [Table 3](#tbl34046){ref-type="table"}, the total scores of GHQ-28 and 3 out of 4 of its subscales, including somatization, anxiety, and social dysfunction, in patients complaining of palpitation were significantly more than healthy participants (34.2 vs. 25.7, P \< 0.001; 8.9 vs. 6.4, P = 0.001; 9.4 vs. 6.4, P \< 0.001; and 12.3 vs. 10.8, P \< 0.007; respectively). Regarding depression subscale, the difference of two groups was not significant (P = 0.089).

###### GHQ-28 Scores of Two Groups^[a](#fn36043){ref-type="table-fn"}^

  Variable ^[b](#fn36044){ref-type="table-fn"}^   Patients With Palpitation   Healthy Persons   P Value
  ----------------------------------------------- --------------------------- ----------------- ---------
  **Total score**                                 34.29 (11.6)                25.7 (11.6)       \< .001
  **Somatization subscale**                       8.96 (3.5)                  6.42 (4.4)        .001
  **Anxiety subscale**                            9.45 (4.3)                  6.43 (3.7)        \< .001
  **Social dysfunction subscale**                 12.38 (2.5)                 10.80 (3.4)       .007
  **Depression subscale**                         3.49 (11.6)                 2.10 (3.3)        .089

^a^Data are presented as mean (SD).

^b^Data are presented for GHQ score.

5. Discussion {#sec131837}
=============

Although palpitation is generally considered as a cardiovascular disease, some studies showed that more than 50% of the patients with a complaint of palpitation had no heart disease ([@A22615R19]) instead usually suffer from psychiatric disorders ([@A22615R1], [@A22615R20]-[@A22615R23]). Clinical experiments have shown that psychiatric causes are prevalent in patients with palpitation and the most common form of these problems are anxiety, depression, and somatoform disorders. These patients experience frequent referrals to cardiology clinics and 10% - 14% of them have panic disorders ([@A22615R4]). As indicated in a study by Barsky et al. about half of the patients with palpitation evaluated by a 24-hour ECG or event recorder, had suffered from psychiatric disorders ([@A22615R24]).

However, our findings indicated that 85.4% of the patients with palpitation had psychiatric disorders and the frequency of mental disorder in them was more than similar group of healthy persons (about twice). Moreover, according to this result, the prevalence of mental disorder (43.6%) in healthy group was more than the results of an extensive study implemented in Iran. That survey, which had a large sample size, had reported that 34.2% of the population in the age group of 15 years and above suffer from mental disorders ([@A22615R25]).

Our findings showed that among the four aspects of mental health evaluated by the GHQ-28, social dysfunction was the most prevalent disorder; however, there is no significant difference between patients with palpitation and healthy participants in this regard. On the other hand, somatization and anxiety had significantly more prevalence in patients with palpitation compared to healthy participants and depression had the least prevalence and did not show any significant difference between the groups.

Jonsbu et al. reported the prevalence of psychiatric disorders in patients with benign palpitation as follows: anxiety disorder 30%, major depression 4%, and any somatoform disorder 15% ([@A22615R1]). Likewise, our findings showed that depression had the least prevalence, however, the prevalences of anxiety, major depression, and somatization were 81.8, 23.6, and 81.8%, respectively.

In some studies, anxiety is considered as the most common non-cardiac cause of palpitation ([@A22615R26]). Some others suggested that panic attacks and somatization are closely related to it ([@A22615R4], [@A22615R5], [@A22615R27]-[@A22615R30]). Furthermore, depression is known as a common cause of palpitation ([@A22615R27], [@A22615R31]-[@A22615R35]). Our findings also indicated that anxiety was the most common disorder in patients, considering it as one of two disorders that were significantly more in patients than healthy persons.

To the best of our knowledge, this is the first study examining Iranian patients with palpitation compared to similar healthy persons; however, as a preliminary evaluation, the use of a screening tool can be considered as a limitation and a clinical psychiatric evaluation is proposed for the next study.

As mentioned before, palpitation is one of the most common symptoms that prompt patients to consult a cardiologist. However, most of the times, it is considered benign and without any cardiac origin. It seems that palpitation is associated with psychiatric symptoms such as anxiety and somatization. Therefore, in psychiatric disorders with symptoms of anxiety and somatization, palpitation is very common. Since the accurate etiology leads to an effective treatment, it is highly recommended that patients with palpitation after a negative evaluation by a cardiologist, be referred for psychiatric assessments.

5.1. Strong Points of Study {#sec131835}
---------------------------

Given the considerable prevalence of palpitation and lack of effective treatment from cardiac point of view, considering a psychiatric origin after rolling out the cardiac underlying causes, may lead to more suitable treatments. Besides, to the best of our knowledge this study is the first one, which evaluates the relationship between palpitation and mental health.

5.2. Weak Points of Study {#sec131836}
-------------------------

GHQ-28 is a screening tool and in order to evaluate more accurately psychiatric disorders such as anxiety, depression, and so on, specific questionnaires for each of them may be necessary, as well as a clinical psychiatric evaluation and a bigger sample size that lead to more statistically valid conclusions.

The article was based on a part of PhD thesis of traditional pharmacy (Fatemeh Alijaniha, No. 127), granted by the school of traditional medicine, Shahid Beheshti university of medical sciences.
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